Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Mol Med Rep ; 16(6): 8420-8426, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28983609

ABSTRACT

Postmenopausal osteoporosis (PMOP) is characterized by increased bone loss due to enhanced osteoclastogenesis and bone resorption. A Chinese herbal formula, jiangugranule (JG), exhibited great efficacy in the clinical treatment of PMOP. However, the molecular mechanisms underlying the therapeutic effects remain unclear. The present study aimed to examine the effects of JG­containing serum on receptor activator of nuclear factor­κB (NF­κB) ligand (RANKL)­induced osteoclastogenesis. Osteoclast precursor RAW264.7 cells were cultured and treated with JG­containing serum in the presence of RANKL. Following 6 days of culture, the cells were stained with tartrate­resistant acid phosphatase and the rate of differentiation was calculated. In addition, cells were treated with JG­containing serum for 24, 48 and 96 h and total RNA and proteins were extracted for reverse transcription­quantitative polymerase chain reaction and western blot analysis to detect mRNA and protein expression, respectively, of key molecules in the RANK/RANKL signaling pathway, including RANK, tumor necrosis factor receptor­associated factor 6, NF­κB (p50 and p52 subunits), c­Fos and nuclear factor of activated T cells, cytoplasmic 1 (NFATc1). The results revealed that JG­containing serum inhibited RANKL­induced osteoclastogenesis and reduced mRNA and protein expression of RANK, c­Fos and NFATc1. The results suggested that JG may regulate osteoclast differentiation through the RANK/RANKL signaling pathway, which may be a possible mechanism for the therapeutic effects of JG on PMOP.


Subject(s)
Bone Resorption/etiology , Bone Resorption/metabolism , Drugs, Chinese Herbal/pharmacology , Osteoclasts/drug effects , Osteoclasts/metabolism , RANK Ligand/metabolism , Animals , Bone Resorption/pathology , Cell Differentiation/drug effects , Chromatography, High Pressure Liquid , Drugs, Chinese Herbal/chemistry , Mice , Osteoclasts/cytology , RANK Ligand/pharmacology , RAW 264.7 Cells , Receptor Activator of Nuclear Factor-kappa B/metabolism , Signal Transduction/drug effects
2.
Nat Prod Commun ; 9(1): 107-10, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24660476

ABSTRACT

The inhibitory effect of binary toxic (Bin) protein produced by Lysinibacillus sphaericus IAB872 on cell proliferation of human lung, liver, stomach and cervical tumor cell lines was assessed using MTT assay. The effect of Bin protein on A549 cell proliferation, apoptosis, cell cycle, migration and invasion were examined by MTT assay, Western blotting, Immunocytochemical staining, flow cytometry assay and wound-healing assay. Results showed that Bin protein inhibits proliferation of a range of human cancer cells in vitro. The anti-proliferative effect of Bin is associated with cell apoptosis as a result of an increased ratio of cellular Bax/bcl-2, up-regulated CyclinB1 and down-regulated Cdc25c expression, and its anti-proliferative action was associated with cell cycle arrest in the G2/M-phase. Bin protein could promote apoptosis and inhibit motility and invasion of A549 cancer cells. The anti-proliferative effect of Bin protein was associated with the induction of apoptotic cell death and cell cycle disruption. These results show that Bin protein has the potential to be developed as a chemotherapeutic agent by induction of human tumor cell apoptosis.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Bacillus/chemistry , Bacterial Toxins/pharmacology , Cell Proliferation/drug effects , Antineoplastic Agents/isolation & purification , Bacterial Toxins/isolation & purification , Cell Cycle Checkpoints/drug effects , Drug Screening Assays, Antitumor , HeLa Cells , Humans
3.
Vascul Pharmacol ; 48(2-3): 129-37, 2008.
Article in English | MEDLINE | ID: mdl-18304881

ABSTRACT

The aim of the present study was to investigate an anti-angiogenic effect of taspine isolated from Radix et Rhizoma Leonticsi. Taspine was screened for the first time, using cell membrane chromatography (CMC). The anti-angiogeneic activity of taspine was tested by using the chicken chorioallantoic membrane (CAM) neovascularisation model in vivo and the HUVEC proliferation and migration models in vitro, respectively. The results showed that taspine could inhibit CAM angiogenesis significantly within the concentration range of 0.5-2 mug/egg, proliferation and migration of endothelial cells in a dose-dependent manner. The CAM histomorphology results indicated that taspine could inhibit blood vessels sprouts and proliferation of vascular endothelial cell. These findings suggest that taspine is a promising candidate for use as an angiogenesis inhibitor.


Subject(s)
Alkaloids/pharmacology , Angiogenesis Inhibitors/pharmacology , Cell Movement/drug effects , Cell Proliferation/drug effects , Chorioallantoic Membrane/blood supply , Endothelial Cells/drug effects , Neovascularization, Physiologic/drug effects , Animals , Cells, Cultured , Chick Embryo , Dose-Response Relationship, Drug , Endothelial Cells/diagnostic imaging , Humans , Plant Extracts/pharmacology , Ultrasonography
4.
Cancer Lett ; 262(1): 103-13, 2008 Apr 08.
Article in English | MEDLINE | ID: mdl-18180095

ABSTRACT

The present study was to demonstrate the effect of taspine isolated from Radix et Rhizoma Leonticis on tumor angiogenesis and its mechanism of action. The anti-angiogenic effect in vivo was evaluated on chicken chorioallantoic membrane (CAM) neovascularisation model and CAM transplantation tumor model. Taspine exerted inhibitory influence on CAM angiogenesis and the growth and microvessel density (MVD) of CAM transplantation tumor at concentrations of 0.5-2µg/egg. The mechanism was demonstrated through detecting vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) protein secretion by enzyme-linked immunosorbent assay (ELISA), as well as mRNA expression of VEGF, Flt-1 and Flk-1/KDR by reverse transcription-polymerase chain reaction (RT-PCR). The results showed that taspine down-regulated the VEGF and bFGF secretion in human non-small cell lung cancer cell (A549 cell) and human umbilical vein endothelial cell (HUVEC), and the VEGF and Flk-1/KDR mRNA expression in HUVEC. Additionally, the effect of taspine on HUVEC migration was detected with the method of cell scrape. The result indicated that taspine inhibited HUVEC migration in a dose-dependent manner. These findings suggest that taspine might be a promising candidate as angiogenesis inhibitors.


Subject(s)
Alkaloids/pharmacology , Angiogenesis Inhibitors/pharmacology , Carcinoma, Non-Small-Cell Lung/drug therapy , Phytotherapy , Plant Preparations/pharmacology , Animals , Carcinoma, Non-Small-Cell Lung/blood supply , Cell Line, Tumor , Chickens , Chorioallantoic Membrane/blood supply , Endothelium, Vascular/drug effects , Humans , Neoplasm Transplantation , Umbilical Veins/drug effects , Vascular Endothelial Growth Factor A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL